Bafna Pharmaceuticals Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 28.49 | 44 | 39.51 |
| Operating Expense | 25.70 | 38.69 | 35.24 |
| Net Profit | 0.08 | 2.75 | 1.84 |
| Net Profit Margin | 0.28% | 6.25% | 4.66% |
| Earning Per Share | 0.03 | 1.16 | 0.78 |
| EBIDTA | 2.80 | 5.31 | 4.27 |
| Effective Tax Rate | 0% | -2.45% | 0% |
Particulars
Jun 2026
Revenue28.49
Operating Expense25.70
Net Profit0.08
Net Profit Margin0.28
Earning Per Share0.03
EBIDTA2.80
Effective Tax Rate0
